# Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study

> **NCT00427882** · PHASE4 · COMPLETED · sponsor: **Handok Inc.** · enrollment: 125 (estimated)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** ALFUZOSIN

## Key facts

- **NCT ID:** NCT00427882
- **Lead sponsor:** Handok Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2007-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427882, "Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00427882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*